Adefovir (Hepsera) for chronic hepatitis B infection.
D000225:Adenine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use* / Q000633:toxicity; D000284:Administration, Oral; D018849:Controlled Clinical Trials as Topic; D003404:Creatinine / Q000097:blood; D024882:Drug Resistance, Viral / Q000502:physiology; D017850:Economics, Pharmaceutical; D005252:Fees, Pharmaceutical; D019694:Hepatitis B, Chronic / Q000188:drug therapy*; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced; D063065:Organophosphonates; D014556:Urine / Q000737:chemistry
D063065:Organophosphonates; C053001:adefovir; D003404:Creatinine; D000225:Adenine